Patients with primary ALL had no correlations between P-gp expression, therapy response, and sensitivity to anthracyclines, and had weak correlations between high expression of P-gp and resistance to cytarabine (r = 0.15) and vincristine (r = 0.06) (Figure 3B, Table S9). Here, PGP is linked to acute lymphoblastic leukemia.